The Europe Digital Health For Cardiovascular Market is expected to witness market growth of 21.7% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $11.65 billion by 2031. The UK market is exhibiting a CAGR of 20.7% during 2024-2031. Additionally, the France market is expected to experience a CAGR of 22.7% during 2024-2031.
The role of artificial intelligence (AI) and machine learning (ML) in digital cardiovascular health is becoming increasingly significant. In order to identify patterns and predict health outcomes, AI algorithms can analyze enormous amounts of health data collected from wearable devices, RPM systems, and electronic health records. Predictive analytics enable healthcare providers to stratify patients based on risk and personalize treatment plans accordingly.
Mobile health (mHealth) applications have also gained traction in cardiovascular health. These apps offer various functionalities, from tracking physical activity, diet, and sleep patterns to providing educational content on heart health and facilitating medication adherence. Some mHealth apps are designed specifically for cardiac rehabilitation programs, offering patients structured exercise plans, monitoring progress, and enabling communication with healthcare providers.
Europe is characterized by a high prevalence of cardiovascular diseases (CVD), such as hypertension, heart failure, and coronary artery disease. This burden on national healthcare budgets and healthcare institutions is substantial. In the same year, 2021, the EU's standardized death rate for cardiovascular system diseases was 343.4 per 100,000 people, with males experiencing this rate at approximately 1.4 times higher than females. Further data from 2021 indicates that the highest standardized death rates for cerebrovascular diseases were recorded in Bulgaria, Latvia, Romania, and Lithuania, while the lowest rates were seen in France and Ireland. Aging populations in many European countries are another contributing factor, as older adults are at a much higher risk of developing cardiovascular conditions such as heart failure, atrial fibrillation, and stroke. CVDs have been the subject of numerous initiatives and strategies at both the EU and national levels in response to the increasing burden. Germany has made significant strides with its Digital Healthcare Act (Digitale-Versorgung-Gesetz, DVG), which became law in 2019. Therefore, the region will present lucrative growth opportunities for the market throughout the forecast period.
The Germany market dominated the Europe Digital Health For Cardiovascular Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $11.65 billion by 2031. The UK market is exhibiting a CAGR of 20.7% during 2024-2031. Additionally, the France market is expected to experience a CAGR of 22.7% during 2024-2031.
The role of artificial intelligence (AI) and machine learning (ML) in digital cardiovascular health is becoming increasingly significant. In order to identify patterns and predict health outcomes, AI algorithms can analyze enormous amounts of health data collected from wearable devices, RPM systems, and electronic health records. Predictive analytics enable healthcare providers to stratify patients based on risk and personalize treatment plans accordingly.
Mobile health (mHealth) applications have also gained traction in cardiovascular health. These apps offer various functionalities, from tracking physical activity, diet, and sleep patterns to providing educational content on heart health and facilitating medication adherence. Some mHealth apps are designed specifically for cardiac rehabilitation programs, offering patients structured exercise plans, monitoring progress, and enabling communication with healthcare providers.
Europe is characterized by a high prevalence of cardiovascular diseases (CVD), such as hypertension, heart failure, and coronary artery disease. This burden on national healthcare budgets and healthcare institutions is substantial. In the same year, 2021, the EU's standardized death rate for cardiovascular system diseases was 343.4 per 100,000 people, with males experiencing this rate at approximately 1.4 times higher than females. Further data from 2021 indicates that the highest standardized death rates for cerebrovascular diseases were recorded in Bulgaria, Latvia, Romania, and Lithuania, while the lowest rates were seen in France and Ireland. Aging populations in many European countries are another contributing factor, as older adults are at a much higher risk of developing cardiovascular conditions such as heart failure, atrial fibrillation, and stroke. CVDs have been the subject of numerous initiatives and strategies at both the EU and national levels in response to the increasing burden. Germany has made significant strides with its Digital Healthcare Act (Digitale-Versorgung-Gesetz, DVG), which became law in 2019. Therefore, the region will present lucrative growth opportunities for the market throughout the forecast period.
List of Key Companies Profiled
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Market Report Segmentation
By Component
- Services
- Software
- Hardware
By End-use
- Patients
- Providers
- Payers
- Other End-use
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Europe Digital Health For Cardiovascular Market by Component
Chapter 6. Europe Digital Health For Cardiovascular Market by End-use
Chapter 7. Europe Digital Health For Cardiovascular Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Apple, Inc.
- Orange S.A.
- Epic Systems Corporation
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- CardiAI.Inc
- Vista.ai (HeartVista, Inc.)
- Viz.ai, Inc.
- Cleerly, Inc.
- RSIP Vision Ltd.
Methodology
LOADING...
